A new publication referencing cerebrolysin was released on July 11, 2026. The article, titled "Predictors of Psychoactive and Nootropic Substance Use Among Romanian University Healthcare Students: The Interplay Between Academic Anxiety and Educational Advancement," appears in the journal Healthcare (Basel, Switzerland).
The publication is indexed under PubMed ID 42512595. Cerebrolysin remains classified as an unapproved research compound. No findings, conclusions, or data from the study are detailed here beyond its title and publication venue.
Readers interested in this topic can consult the original article for full study details, methodology, and results. This brief reports only that the publication has been released and where it appears, without characterizing its content or implications. For further context on cerebrolysin as a compound, see the linked overview.